<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for HISAMITSU PHARMACEUTICAL CO., INC. - Google Finance</title>
<description>News for HISAMITSU PHARMACEUTICAL CO., INC. - Google Finance</description>
<link>http://www.google.co.uk/finance?q=TYO:4530&amp;amp;client=news-rss&amp;amp;ei=L4HCUbCoF-m40QGBtAE</link>
<image>
<title>News for HISAMITSU PHARMACEUTICAL CO., INC. - Google Finance</title>
<url>/finance/s/-vLkpqn8pIU/images/logo_uk.gif</url>
<link>http://www.google.co.uk/finance?q=TYO:4530&amp;amp;client=news-rss&amp;amp;ei=L4HCUbCoF-m40QGBtAE</link>
</image>
<item>
<title>Depomed Fails to Win U.S. Approval for Menopause Drug</title>
<link>http://www.bloomberg.com/news/2013-05-31/depomed-fails-to-win-u-s-approval-for-menopause-drug.html</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778172588371</guid>
<pubDate>Fri, 31 May 2013 23:31:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.bloomberg.com/news/2013-05-31/depomed-fails-to-win-u-s-approval-for-menopause-drug.html&quot; style=&quot;font-size:1.2em&quot;&gt;Depomed Fails to Win U.S. Approval for Menopause Drug&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Bloomberg&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 31, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;The panel reached the same conclusion about another treatment to ease hot flashes from Hisamitsu Pharmaceutical Co. (4530).&lt;/div&gt;
&lt;a href=&quot;http://www.thepharmaletter.com/file/122546/briefs-depomed-drops-sefelsa-after-crl-sun-pharma-stalking-meda.html&quot;&gt;Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;The Pharma Letter&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>R&amp;amp;I Withdraws Rating on HISAMITSU PHARMACEUTICAL CO INC</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2630399</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2630399</guid>
<pubDate>Fri, 26 Oct 2012 06:01:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2630399&quot; style=&quot;font-size:1.2em&quot;&gt;R&amp;amp;I Withdraws Rating on HISAMITSU PHARMACEUTICAL CO INC&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Oct 26, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>HISAMITSU PHARMACEUTICAL CO INC Raises Mid-year Consolidated Outlook for FY 2013</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2612720</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2612720</guid>
<pubDate>Wed, 26 Sep 2012 02:30:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2612720&quot; style=&quot;font-size:1.2em&quot;&gt;HISAMITSU PHARMACEUTICAL CO INC Raises Mid-year Consolidated Outlook for FY 2013&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Sep 26, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hisamitsu Pharmaceutical Co., Ltd. to Dissolve Subsidiary and Sub-subsidiary</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2558301</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2558301</guid>
<pubDate>Mon, 18 Jun 2012 02:30:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2558301&quot; style=&quot;font-size:1.2em&quot;&gt;Hisamitsu Pharmaceutical Co., Ltd. to Dissolve Subsidiary and Sub-subsidiary&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 18, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hisamitsu Pharmaceutical Co., Ltd. to Establish Joint Venture with sanofi-aventis K.K.</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2555651</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2555651</guid>
<pubDate>Tue, 12 Jun 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2555651&quot; style=&quot;font-size:1.2em&quot;&gt;Hisamitsu Pharmaceutical Co., Ltd. to Establish Joint Venture with sanofi-aventis K.K.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jun 12, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hisamitsu Pharmaceutical Co., Ltd. Announces Result of Phase III Clinical Trial for HTU-520</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2526801</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2526801</guid>
<pubDate>Wed, 25 Apr 2012 02:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2526801&quot; style=&quot;font-size:1.2em&quot;&gt;Hisamitsu Pharmaceutical Co., Ltd. Announces Result of Phase III Clinical Trial for HTU-520&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hisamitsu Pharmaceutical Co., Ltd. Forms Capital and Business Alliance with Yutoku Pharmaceutical lnd.Co., Ltd.</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2464223</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2464223</guid>
<pubDate>Tue, 17 Jan 2012 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2464223&quot; style=&quot;font-size:1.2em&quot;&gt;Hisamitsu Pharmaceutical Co., Ltd. Forms Capital and Business Alliance with Yutoku Pharmaceutical lnd.Co., Ltd.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jan 17, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>R&amp;amp;I Affirms Hisamitsu Pharmaceutical Co., Ltd.&amp;#39;s Rating at &amp;quot;A&amp;quot;; Rating Outlook Stable</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2392207</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2392207</guid>
<pubDate>Tue, 30 Aug 2011 06:01:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2392207&quot; style=&quot;font-size:1.2em&quot;&gt;R&amp;amp;I Affirms Hisamitsu Pharmaceutical Co., Ltd.&amp;#39;s Rating at &amp;quot;A&amp;quot;; Rating Outlook Stable&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Aug 30, 2011 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Hisamitsu Pharmaceutical Co., Ltd. Issues FY 2012 Outlook; Amends Midterm and Year-end Dividend Outlook for FY Ending February 2012</title>
<link>http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2359262</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:2359262</guid>
<pubDate>Thu, 07 Jul 2011 06:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/4530.T/key-developments/article/2359262&quot; style=&quot;font-size:1.2em&quot;&gt;Hisamitsu Pharmaceutical Co., Ltd. Issues FY 2012 Outlook; Amends Midterm and Year-end Dividend Outlook for FY Ending February 2012&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jul 7, 2011 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
